Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biofol is an oral nutritional supplement developed by Med Manor Organics, formulated as a combination of biotin (vitamin B7) and folic acid (vitamin B9). It is primarily indicated for the prevention of fetal birth defects, including neural tube defects, and for addressing nutritional deficiencies, anemia, and hair or nail weakness. Folic acid is essential for DNA synthesis, cell division, and red blood cell maturation, acting as a substrate for dihydrofolate reductase and binding to folate receptors. Biotin serves as a vital coenzyme for carboxylases involved in metabolic pathways, supporting keratin production and cellular health. Together, these B-complex vitamins support healthy cellular growth, prenatal development, and general well-being.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on biotin + folic acid (Med Manor Organics).